84,501 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Diversify Wealth Management LLC

Diversify Wealth Management LLC acquired a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 84,501 shares of the real estate investment trust’s stock, valued at approximately $1,720,000.

A number of other hedge funds also recently bought and sold shares of the business. Focus Partners Wealth lifted its stake in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 2,375 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares in the last quarter. First Trust Advisors LP grew its position in shares of Sabra Healthcare REIT by 27.2% in the second quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after purchasing an additional 78,709 shares in the last quarter. Cerity Partners LLC increased its holdings in shares of Sabra Healthcare REIT by 73.0% in the second quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 3.1% in the second quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after purchasing an additional 2,557 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $19.75 on Wednesday. The stock has a market cap of $4.98 billion, a PE ratio of 31.35, a P/E/G ratio of 1.47 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a twelve month low of $17.17 and a twelve month high of $21.28. The stock has a fifty day simple moving average of $19.64 and a 200-day simple moving average of $19.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s quarterly revenue was up 20.9% on a year-over-year basis. During the same period last year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Analyst Ratings Changes

A number of analysts have issued reports on SBRA shares. Scotiabank cut their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Cantor Fitzgerald boosted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Citigroup lowered shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $24.00 to $19.00 in a report on Monday, June 22nd. Truist Financial upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price objective for the company in a research report on Wednesday, July 8th. Finally, UBS Group reduced their target price on shares of Sabra Healthcare REIT from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 8th. Five investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $21.45.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.